{{--
  Back to User
--}}
{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode'])) Logout @endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
Back

A survey to assess the implementation of guideline directed medical therapy (GDMT) for the management of heart failure and assess the impact of Indian heart failure profiling wheel in improving adoption of GDMT - an Indian perspective (RISE)

Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif {{--

--}} @if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif {{-- @if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif --}}
  1. What percentage of patients in your daily practice are diagnosed with heart failure (HF)? *

  2. What percentage of patients in your daily practice are diagnosed with heart failure with reduced ejection fraction? *

  3. What percentage of patients in your daily practice are diagnosed with heart failure with preserved ejection fraction? *

  4. What is the most common reason for visiting emergency or consultation? *

  5. What are the common causes of heart failure? *

  6. Which among the below are considered for diagnosing HF? *

  7. What is the commonest presentation of heart failure in your practice *
  8. What are the diagnostic modalities utilized to diagnose patient with HF*
  9. What are the limiting factors in utilizing NTproBNP biomarker for screening HF? *
  10. Please share is any suggestions to improve utilization of biomarkers in management of HF? *
  11. In clinical practice do you classify heart failure? *

  12. Which is your preferred method of classifying a heart failure patient? *

  13. If classification is done what are the advantages, disadvantages or limitations of classifying? *
  14. What are the four pillars of Heart Failure (HF)? *

  15. What percentage of your patients are on GDMT *

  16. Which drugs according to you are considered under GDMT for heart failure (multiple choice) *

  17. What percentage of HFrEF patients do you prescribe ARNI *

  18. What percentage of HFrEF patients do you prescribe SGLT2i *

  19. What percentage of HFrEF patients do you prescribe BB *

  20. What percentage of HFrEF patients do you prescribe MRA *

  21. What percentage of HFrEF patients do you prescribe ACEi/ARB *

  22. What percentage of HFrEF patients with DM do you prescribe SGLT2i *

  23. What percentage of HFrEF patients without DM do you prescribe SGLT2i *

  24. What percentage of HFrEF patients do you switch from ACEI/ARB to ARNI *

  25. What is your preferred method of therapy initiation in HF? *

  26. What are the major limiting factors in implementation of GDMT? *
  27. Do you identify patient profile while evaluating heart failure patients? *

  28. Which among the below is a major factor in decision making for choice of therapy in HF (Multiple choice question) *

  29. Which parameters do you consider before implementation of GDMT in HF *
  30. Among the list mentioned below which patient profiles do you consider more relevant for modifying therapy choice? *

  31. Please suggest any additional profiles that need to be considered in modifying therapy *
  32. What are the most common limitations in implementation of Sacubitril/valsartan *
  33. What are the most common limitations in implementation of ACEI/ARB *
  34. What are the most common limitations in implementation of MRA *
  35. What are the most common limitations in implementation of Betablockers *
  36. Which among the below is the most common treatment emergent complication leading to stopping therapy (one or multiple drugs) *

  37. Which treatment emergent complication lead to stopping therapy (one or multiple drugs) *
  38. Do you continue diuretic therapy in all patients of HF *

  39. Do you consider reducing dose or stopping diuretics in patients with stable chronic heart failure? *

  40. When do you consider weaning patients off diuretics? *
  41. What is the first preferred step when hypotension is observed in a patient with HF *

  42. Are you aware of Indian Heart failure profiling wheel (IHFPW)? *

  43. Do you consider patient profile-based approach in treatment of heart failure? *

  44. What profiles do you consider should be added to the IHFPW? *
  45. What can be done to manage heart failure?*

  46. Considering clinical practice which drugs among the below are implemented in patients with HFpEF *

  47. What percentage of HF patients are already on Beta blockers at diagnosis?*

  48. What percentage of HF patients are already on ACEI/ARB at diagnosis? *

  49. Please share suggestion for improving IHFPW? *
  50. Please share your suggestions for improving implementation of GDMT in HF *